Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Two Potential Diagnostic Markers for Ischemic Heart Disease Identified

August 2, 2010 7:58 am | News | Comments

A new study identified the potential use of two diagnostic markers for ischemic heart disease.

TOPICS:

Jacketed Reactor Systems

August 2, 2010 7:39 am | Product Releases | Comments

Syrris has upgraded its range of Atlas automated synthesis systems, adding stainless steel reactors and a high temperature upgrade kit.

TOPICS:

Low Volume Dispenser

August 2, 2010 7:22 am | Product Releases | Comments

Redd & Whyte has launched the Preddator S1, an instrument designed for successful dispensing of low volumes of cells, beads, and biochemical reagents into 96- to 3456-well plates.

TOPICS:
Advertisement

Electron Microscopy for Life Sciences

August 2, 2010 7:14 am | Product Releases | Comments

FEI Company released a set of software applications that increase the throughput and ease-of-use of its electron microscopes for biological research.

TOPICS:

Generex Biotechnology Creates Scientific Advisory Board

August 2, 2010 7:07 am | News | Comments

Generex Biotechnology Corporation has created a scientific advisory board in an effort to further its drug development programs, specifically in the areas of oncology and metabolic diseases.

TOPICS:

MorphoSys: Third HuCAL Antibody to Enter Clinical Trials

August 2, 2010 7:05 am | News | Comments

MorphoSys AG announced that it will receive a milestone payment from Novartis in connection with the initiation of a phase 1 clinical trial of a HuCAL-derived, fully human antibody in the therapeutic area of ophthalmology.

TOPICS:

How Stem Cells Determine What Tissue to Become

August 2, 2010 6:58 am | News | Comments

Within 24 hours of culturing adult human stem cells on a new type of matrix, University of Michigan researchers were able to make predictions about how the cells would differentiate, or what type of tissue they would become

TOPICS:

Mining Bacterial Genomes Reveals Hidden Drugs

August 2, 2010 6:53 am | News | Comments

A new tool to excavate bacterial genomes that potentially hide a rich array of pharmaceutical treasures has led to the discovery of a novel antibiotic.

TOPICS:
Advertisement

Study Confirms Potential of PROLOR's hGH

August 2, 2010 6:43 am | News | Comments

PROLOR Biotech, Inc. reported publication of a preclinical studyshowing that human growth hormone (hGH) linked to PROLOR’s carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH.

TOPICS:

Cornerstone Therapeutics, The Cough Company Collaborate

August 2, 2010 6:38 am | News | Comments

Cornerstone Therapeutics Inc. has acquired a license to acquire intellectual property from Alitair Pharmaceuticals, Inc.

TOPICS:

Fluorescent Biosensor Created For Drug Development

July 30, 2010 8:43 am | News | Comments

Researchers at Carnegie Mellon University have developed a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors.

TOPICS:

New Pathway To Parkinson's And Alzheimer's Diseases

July 30, 2010 8:40 am | News | Comments

According to a new study, the cause of brain cell death in cases of Alzheimer's disease, Parkinson's disease, and Huntington's disease may be the untimely transfer of nitric oxide from one protein to another.

TOPICS:

Novartis Ships New Seasonal Flu Vaccine

July 30, 2010 8:30 am | News | Comments

Novartis Vaccines has started shipping seasonal influenza vaccine to U.S. customers for the 2010-2011 season, allowing health care professionals to initiate protection of their patients well in advance of this year’s flu season.

TOPICS:

Optimer Submits MAA for Fidaxomicin

July 30, 2010 8:23 am | News | Comments

Optimer Pharmaceuticals, Inc. announced that it has submitted a Marketing Authorization Application for fidaxomicin to the European Medicines Agency under the European Union’s Centralized Procedure.

TOPICS:

Merck Income Half of Previous Year

July 30, 2010 8:09 am | News | Comments

Drugmaker Merck & Co. reported a 52% drop in second-quarter net income, weighed down by big restructuring charges from buying Schering-Plough Corp., generic competition and other factors.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading